Skip to content

Welcome to Discover Pharma! Today is : November 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    First patient dosed in Resolution Therapeutics’ Emerald study of RTX001 for cirrhosis

    Resolution Therapeutics, a clinical-stage biopharmaceutical company developing regenerative macrophage therapy [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development

    DeuterOncology presents phase 1 data for do-2 MET inhibitor showing tumour control with low side effects

    DeuterOncology, a clinical-stage biotech company developing deuterated cancer therapies, has [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing,Opinion & Events,Pharmaceuticals and therapeutics

    Kling Bio and Sanofi join forces to speed discovery of neutralizing antibodies

    Kling Bio has announced a collaboration and license option agreement [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    New glioblastoma treatment project secures funding from The Brain Tumour Charity

    Medicines Discovery Catapult (MDC) and King’s College London (KCL) have [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Skye completes 26-week CBeyond study of nimacimab and eyes 52-week weight loss data

    Skye Bioscience has reached a key milestone in its CBeyond [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Amorphical names Eden Ben CEO to drive regulatory strategy and expand nano-mineral therapeutics pipeline

    Amorphical has appointed Eden Ben as chief executive officer, as [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    More than 450 companies adopt Veeva RIM to accelerate regulatory submissions

    Veeva Systems announced today that more than 450 companies, including [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Medical devices,Opinion & Events

    ViCentra raises $85M to scale manufacturing and accelerate market penetration of Kaleido insulin patch pump

    ViCentra, a European medical device company redefining insulin delivery for [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    TRIMTECH Therapeutics establishes scientific advisory board to advance targeted protein degradation

    TRIMTECH Therapeutics, a biotech developing small molecule therapeutics that selectively [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    NRG Therapeutics closes oversubscribed £50m series B to advance clinical data in Parkinson’s and proof of concept in ALS/MND

    NRG Therapeutics Ltd, a neuroscience company developing treatments targeting mitochondrial [...]

    May 5, 2026
Previous545556Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • AC Immune advances Parkinson’s and Alzheimer’s pipeline with key clinical milestones ahead
    Categories: Central Nervous System, Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • NEB launches cell-free RNA extraction kit for liquid biopsy research Slug: neb-c
    Categories: Drug Discovery & Development, Genomics and sequencing, Research & Development
  • ABLi reports biomarker changes supporting disease-modifying potential of Parkinson’s drug
    Categories: Central Nervous System, Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top